By clicking the button above, you will be brought to the European Academy of Dermatology website to register
Thursday, September 30, 2021
12:00 PM – 1:30 PM ET
Please note this virtual program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
Aimilios Lallas, MD, MSc, PhD
Associate Professor of Dermatology
First Department of Dermatology, School of Medicine
Faculty of Health Sciences, Aristotle University
Anokhi Jambusaria-Pahlajani, MD, MSCE
Director, Medical Dermatology and Director, Immunosuppression and Transplant Dermatology Clinic
Dell Medical School
Upon the completion of this program, attendees should be able to:
- Discuss the pathogenesis of metastatic basal cell carcinoma (BCC) and the attendant involvement of both aberrant pathways and immune dysfunction
- Examine the epidemiology of basal cell carcinoma including prevalence, risk factors, and disease burden
- Apply NCCN practice guidelines for a multi-disciplinary approach to treatment of locally advanced and metastatic BCC
- Explore the clinical trial data for emerging immunotherapy agents in the treatment of advanced or metastatic basal cell skin cancer
This activity is designed to meet the educational needs of primarily dermatologists, onco-dermatologists, and also medical oncologists, Mohs surgeons, and other healthcare practitioners who care for patients with advanced/metastatic basal cell skin cancer.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live virtual activity for a maximum of 1.50 AMA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with basal cell skin cancer. Credits: 1.50 ANCC Contact Hours
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.50 contact hours of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Med Learning Group makes every effort to develop CME activities that are science based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at email@example.com. Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at firstname.lastname@example.org